Sule Ashish, Borja Annamarie, Chin Tay Jam
Department of General and Vascular Medicine, Tan Tock Seng Hospital, Singapore.
Int J Angiol. 2016 Dec;25(5):e97-e99. doi: 10.1055/s-0034-1544125. Epub 2015 Jun 1.
Portal vein thrombosis (PVT) in a setting of liver metastasis is not easy to treat as it may be portal vein tumor thrombus (PVTT). A 77-year-old male patient was diagnosed as ascending colon carcinoma, underwent right hemicolectomy in 1991 with a recurrence in July 2009. In August 2009, he underwent computed tomography (CT) scan of the abdomen which showed evidence of superior mesenteric vein thrombosis with no liver metastasis. He was started with anticoagulation and decision was to treat long term. He was admitted with mesenteric artery ischemic symptoms in February 2012 on anticoagulation. CT scan abdomen and pelvis in February 2012 showed tumor thrombus involving the superior mesenteric vein, portal vein, and splenic vein with hepatic metastasis. His tumor marker chorioembryonic antigen was 34 µg/L. He was continued on anticoagulation. A repeat CT scan abdomen after 2 years (in January 2014) showed, increase in size of hepatic metastasis, extensive thrombus involving the superior mesenteric vein, portal vein, and splenic vein with collaterals. Mesentery was congested due to extensive superior mesenteric vein thrombus. He finally succumbed in June 2014. It is very important to differentiate PVT from PVTT as the prognosis is different. PVTT progresses despite of long-term anticoagulation with poor prognosis.
肝转移情况下的门静脉血栓形成(PVT)不易治疗,因为它可能是门静脉肿瘤血栓(PVTT)。一名77岁男性患者被诊断为升结肠癌,1991年接受了右半结肠切除术,2009年7月复发。2009年8月,他接受了腹部计算机断层扫描(CT),显示有肠系膜上静脉血栓形成但无肝转移。开始给予抗凝治疗并决定长期治疗。2012年2月,他在接受抗凝治疗时因肠系膜动脉缺血症状入院。2012年2月的腹部和骨盆CT扫描显示肿瘤血栓累及肠系膜上静脉、门静脉和脾静脉,并伴有肝转移。他的肿瘤标志物绒毛膜促性腺激素为34μg/L。继续给予抗凝治疗。2年后(2014年1月)重复进行腹部CT扫描显示,肝转移灶增大,广泛血栓累及肠系膜上静脉、门静脉和脾静脉并伴有侧支循环。由于广泛的肠系膜上静脉血栓形成,肠系膜充血。他最终于2014年6月死亡。区分PVT和PVTT非常重要,因为预后不同。尽管长期抗凝,PVTT仍会进展,预后较差。